Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 5410  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others


Deflazacort versus other glucocorticoids: A comparison

Nayak Surajit, Acharjya Basanti

Year : 2008| Volume: 53| Issue : 4 | Page no: 167-170

   This article has been cited by
1 Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy
Kelsie D. Kracht, Nicole L. Eichorn, Daniel J. Berlau
Expert Opinion on Pharmacotherapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
W. Douglas Biggar, Andrew Skalsky, Craig M. McDonald
Journal of Neuromuscular Diseases. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, Patricia Hafner, Nuri Gueven, Dirk Fischer, Emma Rybalka
Orphanet Journal of Rare Diseases. 2021; 16(1)
[Pubmed]  [Google Scholar] [DOI]
4 Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy
Perry B Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W Peltz, Julie A Parsons, Susan Apkon, Basil T Darras, Craig Campbell, Craig M McDonald, Richard J Barohn, Enrico Bertini, Kate Bushby, Brigitte Chabrol, Emma Ciafaloni, Jaume Columer, Giacomi Pietro Comi, Anne Connolly, Richard S Finkel, Kevin M Flanigan, Nathalie Goemans, Michela Guglieri, Susan T Iannaccone, Kristi J Jones, Petra Kaufmann, Janbernd Kirschner, Jean K Mah, Katherine Mathews, Eugenio Mercuri, Francesco Muntoni, Yoram Nevo, Andrés Nascimento Osorio, Yann Péréon, Rosaline Quinlivan, J. Ben Renfroe, Barry Russman, Monique Ryan, Jacinda Sampson, Ulrike Schara, Kathryn Selby, Thomas Sejersen, Douglas M Sproule, H. Lee Sweeney, Már Tulinius, Juan J Vilchez, Giuseppe Vita, Thomas Voit, Stephanie Burns-Wechsler, Brenda Wong, Ted Abresch, Erik K Henricson, Kim Coleman, Michelle Eagle, Julaine Florence, Ed Gappmaier, Craig McDonald, Hoda Z Abdel-Hamid, Richard J Barohn, Enrico Bertini, Clemens Bloetzer, Kat
Journal of Comparative Effectiveness Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Role of Tamsulosin with or without Deflazacort to facilitate stone clearance after ESWL: a single-center randomized controlled study
Saurabh Jain, Mahendra Singh, Sudhir Khanna, Shahnawaz Rasool, Manu Gupta, Sachin Kathuria, Amrendra Pathak, Himanshu Pandey
African Journal of Urology. 2020; 26(1)
[Pubmed]  [Google Scholar] [DOI]
6 Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center
Jessica R Marden, Jonathan Freimark, Zhiwen Yao, James Signorovitch, Cuixia Tian, Brenda L Wong
Journal of Comparative Effectiveness Research. 2020; 9(3): 177
[Pubmed]  [Google Scholar] [DOI]
7 Deflazacort-induced Acneiform Eruptions
Mohammed ShakeelMohammed Bashir, Mohammad Saleem, Uday Choudhari
Journal of Pharmacy And Bioallied Sciences. 2017; 9(4): 284
[Pubmed]  [Google Scholar] [DOI]
8 Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome
Ravish Singhal,Sadbhavna Pandit,Neeraj Dhawan
Iranian Journal of Pediatrics. 2015; 25(2)
[Pubmed]  [Google Scholar] [DOI]
9 Renal function in children and adolescents with Duchenne muscular dystrophy
Elke Braat,Liesbeth Hoste,Liesbeth De Waele,Olivier Gheysens,Pieter Vermeersch,Karolien Goffin,Hans Pottel,Nathalie Goemans,Elena Levtchenko
Neuromuscular Disorders. 2015;
[Pubmed]  [Google Scholar] [DOI]
10 Comparative Efficacy of Tamsulosin Versus Tamsulosin With Tadalafil in Combination With Prednisolone for the Medical Expulsive Therapy of Lower Ureteric Stones: A Randomized Trial
Santosh Kumar,Kumar Jayant,Swati Agrawal,Shrawan Kumar Singh
Korean Journal of Urology. 2014; 55(3): 196
[Pubmed]  [Google Scholar] [DOI]
11 Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome
Seung Jin Lee,Bong Hwa Kang,Min Hyun Cho
Journal of the Korean Society of Pediatric Nephrology. 2014; 18(2): 123
[Pubmed]  [Google Scholar] [DOI]
12 Randomized Controlled Trial to Compare the Safety and Efficacy of Naftopidil and Tamsulosin as Medical Expulsive Therapy in Combination With Prednisolone for Distal Ureteral Stones
Santosh Kumar,Kailash Chand Kurdia,Raguram Ganesamoni,Shrawan Kumar Singh,Bhuvanesh Nanjappa
Korean Journal of Urology. 2013; 54(5): 311
[Pubmed]  [Google Scholar] [DOI]
13 Systemic use of non-biologic corticosteroids in orofacial diseases
EA Georgakopoulou,C Scully
Oral Diseases. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
14 Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones
Kumar, S. and Kurdia, K.C. and Ganesamoni, R. and Singh, S.K. and Nanjappa, B.
Korean Journal of Urology. 2013; 54(5): 311-315
[Pubmed]  [Google Scholar]
15 Toxicity study of deflazacort on morphological development in zebrafish embryos
R. B. Suresh Kumar,Biswakanth Kar,Narayan Dolai,Indrajit Karmakar,Asis Bala,Pallab Kanti Haldar
Comparative Clinical Pathology. 2013; 22(6): 1205
[Pubmed]  [Google Scholar] [DOI]
16 Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenhamæs chorea
Fusco, C. and Ucchino, V. and Frattini, D. and Pisani, F. and Giustina, E.D.
European Journal of Paediatric Neurology. 2012; 16(4): 373-378
[Pubmed]  [Google Scholar]
17 Corticosteroids in rheumatology: Use, misuse or plain abuse?
Handa, R.
Journal of Association of Physicians of India. 2012; 60(4): 41-45
[Pubmed]  [Google Scholar]
18 Central serous chorioretinopathy after renal transplantation
Lee, C.S. and Kang, E.C. and Lee, K.S. and Byeon, S.H. and Koh, H.J. and Lee, S.C.
Retina. 2011; 31(9): 1896-1903
[Pubmed]  [Google Scholar]
19 Treatment of intraepidermal autoimmune bullous diseases [İntraepidermal otoimmün büllöz hastaliklarin tedavisi]
Kaya, T.I.
Turkderm Deri Hastaliklari ve Frengi Arsivi. 2011; 45(SUPPL. 1): 44-53
[Pubmed]  [Google Scholar]
20 Anti-inflammatory glucocorticoid drugs: reflections after 60 years
Michael W. Whitehouse
Inflammopharmacology. 2011; 19(1): 1
[HTML Full text]  [Google Scholar] [DOI]
21 Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea
Carlo Fusco, Valentina Ucchino, Daniele Frattini, Francesco Pisani, Elvio Della Giustina
European Journal of Paediatric Neurology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
22 Treatment of intraepidermal autoimmune bullous diseases | [İntraepidermal otoimmün büllöz hastaliklarin tedavisi]
Kaya, T.I.
Turkderm Deri Hastaliklari ve Frengi Arsivi. 2011; 45 ( sup 1): 44-53
[Pubmed]  [Google Scholar]
Christopher Seungkyu Lee, Eui Chun Kang, Kyu Sung Lee, Seok Ho Byeon, Hyoung Jun Koh, Sung Chul Lee
Retina. 2011; 31(9): 1896
[HTML Full text]  [Google Scholar] [DOI]
24 Authoræs reply
Saini, M., Khurana, D.
Annals of Indian Academy of Neurology. 2010; 13(2): 152-153
[Pubmed]  [Google Scholar]
25 Authoræs reply
Saini, M. and Khurana, D.
Annals of Indian Academy of Neurology. 2010; 13(2): 152-153
[Pubmed]  [Google Scholar]


Read this article